Bridgebio Oncology Therapeutics, Inc. · NASDAQ:BBOT
Bridgebio Oncology Therapeutics, Inc. shareholders
As of Jun 30, 2026, 64 institutions reported holding Bridgebio Oncology Therapeutics, Inc., 73.8% of its shares. Largest: Cormorant Asset Management, LP, Deerfield Management Company, L.P. and Omega Fund Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Bridgebio Oncology Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 17.9M | 22.3% | no change | Aug 14, 2026 |
| Deerfield Management Company, L.P. | 4.89M | 6.1% | no change | Aug 14, 2026 |
| Omega Fund Management, LLC | 3.29M | 4.1% | no change | Aug 14, 2026 |
| EcoR1 Capital, LLC | 2.82M | 3.5% | no change | Aug 14, 2026 |
| Alphabet Inc. | 2.82M | 3.5% | no change | Aug 7, 2026 |
| Wellington | 2.79M | 3.5% | −29,046 | Aug 14, 2026 |
| Enavate Sciences Gp, LLC | 2.63M | 3.3% | no change | Aug 14, 2026 |
| Citadel | 2.62M | 3.3% | +89,065 | Aug 14, 2026 |
| Vanguard | 2.32M | 2.9% | +1.5M | Aug 13, 2026 |
| Novo Holdings A/S | 2.25M | 2.8% | +64,077 | Aug 14, 2026 |